CastleKnight Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-162,599
Closed -$1.13M 359
2025
Q3
$1.13M Sell
162,599
-192,800
-54% -$1.36M 0.02% 308
2025
Q2
$2.1M Hold
355,399
0.06% 203
2025
Q1
$2.27M Sell
355,399
-90,200
-20% -$870K 0.09% 141
2024
Q4
$5.29M Buy
+445,599
New +$7.6M 0.15% 82
2024
Q1
Sell
-105,400
Closed -$1.66M 339
2023
Q4
$1.66M Sell
105,400
-204,800
-66% -$2.11M 0.09% 127
2023
Q3
$2.67M Hold
310,200
0.18% 85
2023
Q2
$2.45M Sell
310,200
-41,400
-12% -$288K 0.26% 67
2023
Q1
$2.62M Buy
351,600
+108,700
+45% +$1.08M 0.27% 60
2022
Q4
$2.86M Buy
+242,900
New +$2.78M 0.38% 37

Other funds holding ASPN

CastleKnight Management's ASPN Position: Q4 2025 in Review

CastleKnight Management sold out of Aspen Aerogels (ASPN) in Q4 2025, closing a stake of 162,599 shares — an estimated $1.13M sold.

CastleKnight Management first reported a position in ASPN in Q4 2022 and held it in 9 quarters. The position peaked at $5.29M in Q4 2024. 183 funds tracked by Wall St. Rank hold ASPN as of Q4 2025.

  • CastleKnight Management reported no remaining Aspen Aerogels position as of Q4 2025 after selling out during the quarter.
  • CastleKnight Management sold 162,599 Aspen Aerogels shares in Q4 2025, an estimated $1.13M.
  • CastleKnight Management first reported a position in Aspen Aerogels in Q4 2022 and held it in 9 quarters.
  • CastleKnight Management's Aspen Aerogels position peaked at $5.29M in Q4 2024.
  • 183 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2025.

Based on CastleKnight Management's 13F filing for Q4 2025, filed 17 Feb 2026.